Market pull-first review
Start from company, infrastructure, industry, public-sector, or regional priorities before selecting the most relevant IP.
For Universities & Labs
Turn IP portfolios into fundable opportunity pathways.
Arns helps universities and labs convert patents, research, know-how, software, facilities, faculty capability, and student talent into Sponsored Opportunity Development packages anchored in real market pull.
What changes
The portfolio becomes an opportunity field, not a static catalog.
Arns does not ask universities to immediately license, disclose, fund, or launch. The first output is a correction surface: a one-page snapshot or brief showing how selected IP might connect to market pull, external complements, sponsor logic, and venture-building pathways.
IP + complement matching
Identify which university assets are direct fits, enabling fits, complementary fits, or not relevant to the opportunity.
Sponsor-path design
Show which external parties benefit and why they may fund the next validation step.
Student venture participation
Design opportunities where students, graduate teams, MBA/engineering pairs, or founders-in-residence can build around IP when appropriate.
Faculty and center routing
Identify where faculty input, center capabilities, datasets, testing, or facilities could strengthen the route.
Governed external use
Prepare sponsor-facing materials only after the university corrects the map and approves what can be shared.
What the university receives
A repeatable Sponsored Opportunity Development package.
- Opportunity thesis
- Market-pull map
- Core IP anchor
- Complementary IP/capability candidates
- Business model hypothesis
- Sponsor/funder logic
- Venture-building route
- 90-day execution plan
- Go/no-go/redirect decision gates
Best first step
Start with one portfolio area or one market pull.
Examples: SAF, water, agriculture, carbon, AI, materials, health, clean energy, mobility, defense, circular economy, or a specific company priority. Arns can generate a first set of snapshots for internal review.